Literature DB >> 24879316

Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia).

Nataša Vučinić1, Igor Djan, Edita Stokić, Biljana Božin, Dragana Obreht, Karmen Stankov, Mihajla Djan.   

Abstract

The metabolic syndrome (MetS) is a polygenic multifactorial metabolic disorder with strong socioeconomic influence. MetS has became a worldwide epidemic, that directly increases the risk of cardiovascular diseases and type 2 diabetes mellitus. The human apoE gene, coding Apolipoprotein E, has three common polymorphisms in human population: e2, e3 and e4, which are proved to be associated with impaired lipid metabolism. The contribution of apoE polymorphism to MetS disorders has not been investigated previously in Vojvodina Province, region with the highest number of obese people in Serbia. The aim of this study was to evaluate apoE gene polymorphism in relation to MetS disorders. The healthy control group of 30 individuals and 63 MetS patients were examined for apoE variants in relation to biochemical and anthropometric parameters. The genotypes were determined by PCR-RFLP. Regarding all parameters, significantly higher values were detected in MetS group compared to control. The MetS group of patients had significantly higher frequency of e4 allele. In addition, positive relation was revealed between e4 allele presence and all measured parameters. It was found that the e4 allele was related with a significantly increased OR of MetS disorders according to the International Diabetes Federation definition. These results suggested that e4 allele may act as a one of determinants for development of metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24879316     DOI: 10.1007/s11033-014-3390-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

1.  APOE distribution in world populations with new data from India and the UK.

Authors:  P P Singh; M Singh; S S Mastana
Journal:  Ann Hum Biol       Date:  2006 May-Jun       Impact factor: 1.533

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study.

Authors:  J Y Oh; E Barrett-Connor
Journal:  Clin Genet       Date:  2001-08       Impact factor: 4.438

5.  Different associations of apolipoprotein E polymorphism with metabolic syndrome by sex in an elderly Chinese population.

Authors:  Meng Hua Tao; Jian Wei Liu; Michael J LaMonte; Jing Liu; Lei Wang; Yao He; Xiao Ying Li; Lu Ning Wang; Ling Ye
Journal:  Metabolism       Date:  2011-05-06       Impact factor: 8.694

6.  Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.

Authors:  D L Sparks; D J Connor; M N Sabbagh; R B Petersen; J Lopez; P Browne
Journal:  Acta Neurol Scand Suppl       Date:  2006

7.  Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity.

Authors:  Neena Srivastava; B R Achyut; Jai Prakash; C G Agarwal; D C Pant; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-05-04       Impact factor: 3.396

8.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.

Authors:  J Dallongeville; S Lussier-Cacan; J Davignon
Journal:  J Lipid Res       Date:  1992-04       Impact factor: 5.922

Review 9.  Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity.

Authors:  Kyriakos E Kypreos; Iordanes Karagiannides; Elisavet H Fotiadou; Eleni A Karavia; Maria S Brinkmeier; Smaragda M Giakoumi; Eirini M Tsompanidi
Journal:  FEBS J       Date:  2009-09-15       Impact factor: 5.542

10.  ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome.

Authors:  O Olivieri; N Martinelli; A Bassi; E Trabetti; D Girelli; F Pizzolo; S Friso; P F Pignatti; R Corrocher
Journal:  Clin Exp Med       Date:  2008-01-11       Impact factor: 3.984

View more
  4 in total

Review 1.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

Review 2.  Beyond the CNS: The many peripheral roles of APOE.

Authors:  Ana B Martínez-Martínez; Elena Torres-Perez; Nicholas Devanney; Raquel Del Moral; Lance A Johnson; Jose M Arbones-Mainar
Journal:  Neurobiol Dis       Date:  2020-02-19       Impact factor: 5.996

3.  The apolipoprotein E polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men.

Authors:  M Teresa Tejedor; Maria Pilar Garcia-Sobreviela; Marta Ledesma; Jose M Arbones-Mainar
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

4.  The LRP1 Gene Polymorphism is associated with Increased Risk of Metabolic Syndrome Prevalence in the Serbian Population.

Authors:  N Vučinić; E Stokić; I Djan; D Obreht; N Veličković; K Stankov; M Djan
Journal:  Balkan J Med Genet       Date:  2017-06-30       Impact factor: 0.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.